GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invacare Corp (OTCPK:IVCRQ) » Definitions » Days Sales Outstanding

Invacare (Invacare) Days Sales Outstanding : 47.04 (As of Mar. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Invacare Days Sales Outstanding?

Invacare's average Accounts Receivable for the three months ended in Mar. 2023 was $85.3 Mil. Invacare's Revenue for the three months ended in Mar. 2023 was $165.5 Mil. Hence, Invacare's Days Sales Outstanding for the three months ended in Mar. 2023 was 47.04.

The historical rank and industry rank for Invacare's Days Sales Outstanding or its related term are showing as below:

IVCRQ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.67   Med: 46.81   Max: 52.98
Current: 46.31

During the past 13 years, Invacare's highest Days Sales Outstanding was 52.98. The lowest was 42.67. And the median was 46.81.

IVCRQ's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 63.94 vs IVCRQ: 46.31

Invacare's Days Sales Outstanding declined from Mar. 2022 (50.64) to Mar. 2023 (47.04).


Invacare Days Sales Outstanding Historical Data

The historical data trend for Invacare's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invacare Days Sales Outstanding Chart

Invacare Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.05 46.49 48.32 47.13 50.36

Invacare Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.64 47.63 45.80 42.29 47.04

Competitive Comparison of Invacare's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Invacare's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invacare's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invacare's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Invacare's Days Sales Outstanding falls into.



Invacare Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Invacare's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (116.71 + 87.952) / 2 ) / 741.733*365
=102.331 / 741.733*365
=50.36

Invacare's Days Sales Outstanding for the quarter that ended in Mar. 2023 is calculated as:

Days Sales Outstanding (Q: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (87.952 + 82.659) / 2 ) / 165.481*365 / 4
=85.3055 / 165.481*365 / 4
=47.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invacare  (OTCPK:IVCRQ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Invacare Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Invacare's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Invacare (Invacare) Business Description

Traded in Other Exchanges
N/A
Address
One Invacare Way, Elyria, OH, USA, 44035-4190
Invacare Corp makes and distributes medical equipment used in non-acute care settings. Its products are primarily sold to home medical equipment providers, residential living operators, distributors, and government health services. The firm sells products in three categories: mobility and seating, lifestyle, and respiratory therapy. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, and positioning cushions. Its lifestyle products include manual wheelchairs, crutches, walkers, and homecare beds. Its respiratory products include stationary and portable oxygen concentrators and non-delivery oxygen technology. Invacare receives the largest proportion of revenue from sales in Europe.
Executives
Tenor Opportunity Master Fund, Ltd. 10 percent owner 810 SEVENTH AVENUE, SUITE 1905, NEW YORK NY 10019
Randel G Owen director C/O EMERGENCY MEDICAL SERVICES CORP, 6200 SOUTH SYRACUSE WAY, GREENWOOD VILLAGE CO 80111
Kimberly Herman director 3 HUNTINGTON QUADRANGLE, STE 25, MELVILLE NY 11747
Marec Elden Edgar director 1420 KENSINGTON ROAD, SUITE 220, OAK BROOK IL 60523
Elliot Bossen 10 percent owner 3100 TOWER BLVD, UNIVERSITY TOWER STE 1104, DURHAM NC 27707
Silverback Asset Management Llc 10 percent owner 1414 RALEIGH ROAD, SUITE 250, CHAPEL HILL NC 27517
Peter J. Kuipers director 590 E. MIDDLEFEILD ROAD, MOUNTAIN VIEW CA 94043
Tenor Capital Management Co., L.p. 10 percent owner 810 SEVENTH AVENUE, SUITE 1905, NEW YORK NY 10019
Pm Manager Fund, Spc-segregated Portfolio 33 10 percent owner 190 ELGIN AVE, GEORGE TOWN, GRAND CAYMAN E9 KYI-9005
Dov Gertzulin 10 percent owner C/O DG CAPITAL MANAGEMENT, LLC, 460 PARK AVENUE, 22ND FLOOR, NEW YORK NY 10022
Dg Capital Management, Llc 10 percent owner 460 PARK AVENUE, 22ND FLOOR, NEW YORK NY 10022
Endurant Capital Management Lp 10 percent owner 66 BOVET ROAD, SUITE 353, SAN MATEO CA 94402
Abraham T Han director 51 MIDLAND AVENUE, WYCKOFF NJ 07481
Dg Value Partners Ii Master Fund, Lp 10 percent owner 460 PARK AVENUE, 22ND FLOOR, NEW YORK NY 10022
Quang Minh Pham 10 percent owner 66 BOVET ROAD, SUITE 353, SAN MATEO CA 94402

Invacare (Invacare) Headlines